Treatment of advanced soft tissue sarcomas with low-dose methotrexate: a phase II trial by the European Organization of Research on Treatment for Cancer (EORTC) Soft Tissue and Bone Sarcoma Group

MeSH terms

• Adolescent
• Adult
• Aged
• Blood Cell Count
• Drug Administration Schedule
• Female
• Humans
• Male
• Methotrexate / administration & dosage*
• Methotrexate / adverse effects
• Middle Aged
• Sarcoma / drug therapy*
• Soft Tissue Neoplasms / drug therapy*
• Stomatitis / chemically induced